EVERY MODALITY CHALLENGE
ONE STANDARD OF PERFORMANCE
Every bioprocess modality has its own challenges—scale, sensitivity, speed, and endurance are all critical.
Whether monoclonal antibody, vaccine, cell therapy, gene therapy, recombinant protein, or industrial biotechnology manufacturing, ABEC supports a broad range of modalities with integrated bioprocess solutions engineered to deliver reliable performance, reduce risk, and adapt as programs evolve.
Meeting every modality demand with consistency, accountability, and long-term value.
Monoclonal Antibodies
Engineered monoclonal antibody manufacturing solutions that deliver consistency, reproducibility, and confidence across development through commercial mAb production.
Vaccines
Bioprocess solutions designed for repeatable performance under pressure—supporting rapid deployment, reliable scale, and sustained vaccine manufacturing.
Cell Therapy
Integrated biopharma systems built to support sensitive cell therapy workflows with reproducibility, reduced risk, and scalable manufacturing strategies.
Gene Therapy
Biomanufacturing solutions engineered to optimize complex viral vector processes with predictable scale-out, reduced variability, and dependable execution.
Recombinant Proteins
Flexible bioprocess solutions designed to perform across diverse expression systems, operating conditions, and recombinant protein production scales.
Industrial Biotechnology
Durable, high-utilization biopharma solutions engineered for continuous operation, efficiency, and long-term industrial performance.